Sarepta Therapeutics
SRPT
SRPT
361 hedge funds and large institutions have $1.42B invested in Sarepta Therapeutics in 2025 Q2 according to their latest regulatory filings, with 64 funds opening new positions, 160 increasing their positions, 88 reducing their positions, and 128 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
50% less first-time investments, than exits
New positions opened: 64 | Existing positions closed: 128
74% less capital invested
Capital invested by funds: $5.49B → $1.42B (-$4.08B)
100% less funds holding in top 10
Funds holding in top 10: 5 → 0 (-5)
Holders
361
Holding in Top 10
–
Calls
$132M
Puts
$79.5M
Top Buyers
| 1 | +$191M | |
| 2 | +$94.2M | |
| 3 | +$72.9M | |
| 4 |
Two Sigma Investments
New York
|
+$68.7M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$66.8M |
Top Sellers
| 1 | -$365M | |
| 2 | -$171M | |
| 3 | -$149M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$142M |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
-$82.5M |